Pricing Log in Create free account

Labcorp Holdings Inc. (LH) vs Natera, Inc. (NTRA)

Labcorp Holdings Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $58.4B against $26.4B — 2.2× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Labcorp Holdings Inc. trades at 26.2×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 6.41%. Labcorp Holdings Inc. has the higher net margin (6.99% vs −7.11%) and the higher return on invested capital (6.50% vs −22.3%). Across the 20 metrics below, Labcorp Holdings Inc. leads on 14 and Natera, Inc. on 6.

Valuation

Metric LH NTRA Diagnostics & Research median
P/E 26.18 n/m 35.56
P/S 1.81 20.75 4.37
P/B 3.02 30.83 3.06
Price to free cash flow 25.22 667.04 35.76
EV/EBITDA 14.51 n/m 24.35
EV/Sales 2.22 20.48 5.51
Earnings yield 3.82% (0.35%) (1.89%)
Free cash flow yield 3.97% 0.15% (0.15%)

Profitability

Metric LH NTRA Diagnostics & Research median
Gross margin 28.88% 65.23% 50.89%
Operating margin 10.43% (10.70%) (8.57%)
Net margin 6.99% (7.11%) (6.37%)
Free cash flow margin 8.16% 3.11% 0.00%
Return on equity 11.74% (12.54%) (2.92%)
Return on assets 5.48% (8.71%) (6.71%)
Return on invested capital 6.50% (22.34%) 0.00%

Growth

Metric LH NTRA Diagnostics & Research median
Revenue growth (TTM) 6.41% 37.82% 7.69%
EPS growth (last fiscal year) 18.33% 0.65% 25.92%
Revenue growth, 5-year CAGR (0.04%) 42.61% 7.40%
Net income growth, 5-year CAGR (10.85%) 0.00% 0.00%

Health

Metric LH NTRA Diagnostics & Research median
Debt to equity 0.69 0.04 0.11
Current ratio 1.80 3.00 2.02
Net debt to EBITDA 2.23 3.74 0.70

Dividend

Metric LH NTRA Diagnostics & Research median
Dividend yield 0.90% — 0.66%
Payout ratio 0.24 — 0.20

Size

Metric LH NTRA Diagnostics & Research median
Market cap 26.36b 58.35b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack